My Quote Request
No products added yet
6505-01-462-9917
20 Products
ULTRAM
TRAMADOL HYDROCHLOR
NSN, MFG P/N
6505014629917
NSN
6505-01-462-9917
MFG
ORTHO MCNEIL PHARMACEUTICAL INC /JANSSEN/
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: TRAMADOL HYDROCHLORIDE TABLETS, 50 MG; BOTTLE OF 100
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRAMADOL HYDROCHLORIDE TABLETS 50MG 100S BT
Related Searches:
NDC50458-0659-60
TRAMADOL HYDROCHLOR
NSN, MFG P/N
6505014629917
NSN
6505-01-462-9917
MFG
ORTHO MCNEIL PHARMACEUTICAL INC /JANSSEN/
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: TRAMADOL HYDROCHLORIDE TABLETS, 50 MG; BOTTLE OF 100
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRAMADOL HYDROCHLORIDE TABLETS 50MG 100S BT
Related Searches:
NDC65162-0627-10
TRAMADOL HYDROCHLOR
NSN, MFG P/N
6505014629917
NSN
6505-01-462-9917
MFG
AMNEAL PHARMACEUTICALS LLC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: TRAMADOL HYDROCHLORIDE TABLETS, 50 MG; BOTTLE OF 100
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRAMADOL HYDROCHLORIDE TABLETS 50MG 100S BT
Related Searches:
99-0123
LAMIVUDINE AND ZIDOVUDINE TABLETS
NSN, MFG P/N
6505014629945
NSN
6505-01-462-9945
99-0123
LAMIVUDINE AND ZIDOVUDINE TABLETS
NSN, MFG P/N
6505014629945
NSN
6505-01-462-9945
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LAMIVUDINE AND ZIDOVUDINE TABLETS 60S BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: LAMIVUDINE AND ZIDOVUDINE TABLETS; 150MG LAMIVUDINE AND 300MG ZIDOVUDINE
Related Searches:
COMBIVIR
LAMIVUDINE AND ZIDOVUDINE TABLETS
NSN, MFG P/N
6505014629945
NSN
6505-01-462-9945
COMBIVIR
LAMIVUDINE AND ZIDOVUDINE TABLETS
NSN, MFG P/N
6505014629945
NSN
6505-01-462-9945
MFG
GLAXO WELLCOME INC
Description
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LAMIVUDINE AND ZIDOVUDINE TABLETS 60S BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: LAMIVUDINE AND ZIDOVUDINE TABLETS; 150MG LAMIVUDINE AND 300MG ZIDOVUDINE
Related Searches:
NDC00173-0595-00
LAMIVUDINE AND ZIDOVUDINE TABLETS
NSN, MFG P/N
6505014629945
NSN
6505-01-462-9945
NDC00173-0595-00
LAMIVUDINE AND ZIDOVUDINE TABLETS
NSN, MFG P/N
6505014629945
NSN
6505-01-462-9945
MFG
AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE
Description
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LAMIVUDINE AND ZIDOVUDINE TABLETS 60S BT
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: LAMIVUDINE AND ZIDOVUDINE TABLETS; 150MG LAMIVUDINE AND 300MG ZIDOVUDINE
Related Searches:
006-0535044-00
CONTACT LENS CLEANING SOLUTION
NSN, MFG P/N
6505014630173
NSN
6505-01-463-0173
006-0535044-00
CONTACT LENS CLEANING SOLUTION
NSN, MFG P/N
6505014630173
NSN
6505-01-463-0173
MFG
WILSON OPHTHALMIC CORPORATION
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CONTACT LENS CLEANING SOLUTION MULTI-PURPOSE 12OZ BT
PRIMARY CONTAINER CONTENT QUANTITY: 12.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: MULTI-PURPOSE CONTACT LENS SOLUTION
Related Searches:
98-1219
CONTACT LENS CLEANING SOLUTION
NSN, MFG P/N
6505014630173
NSN
6505-01-463-0173
98-1219
CONTACT LENS CLEANING SOLUTION
NSN, MFG P/N
6505014630173
NSN
6505-01-463-0173
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CONTACT LENS CLEANING SOLUTION MULTI-PURPOSE 12OZ BT
PRIMARY CONTAINER CONTENT QUANTITY: 12.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: MULTI-PURPOSE CONTACT LENS SOLUTION
Related Searches:
R2625
RETINOIC ACID POWDE
NSN, MFG P/N
6505014631250
NSN
6505-01-463-1250
MFG
SIGMA CHEMICAL CO
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: VITAMIN A ACID TRETINOIN; 300.4 MOLECULAR WEIGHT; SEALED AMPULE; STORE AT LESS THAN 0 DEG C
Related Searches:
129864
BARIUM SULFATE SUSPENSION,USP
NSN, MFG P/N
6505014633151
NSN
6505-01-463-3151
MFG
LAFAYETTE PHARMACAL INC DIAGNOSTIC PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 PERCENTAGE, W/W BARIUM SULFATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1900.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: IMAGER AC; BARIUM SULFATE SUSPENSION; LOW VISCOSITY, RAPID FLOWING BARIUM SULFATE SUSPENSION FOR DOUBLE CONTRAST EXAMINATIONS OF THE COLON; READY-TO-USE; UNIFORM, CONSISTANT COATING; SIMETHICONE ADDED
TOTAL PRIMARY CONTAINER QUANTITY: 4
Related Searches:
267933
BARIUM SULFATE SUSPENSION,USP
NSN, MFG P/N
6505014633151
NSN
6505-01-463-3151
MFG
PICKER INTL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 PERCENTAGE, W/W BARIUM SULFATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1900.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: IMAGER AC; BARIUM SULFATE SUSPENSION; LOW VISCOSITY, RAPID FLOWING BARIUM SULFATE SUSPENSION FOR DOUBLE CONTRAST EXAMINATIONS OF THE COLON; READY-TO-USE; UNIFORM, CONSISTANT COATING; SIMETHICONE ADDED
TOTAL PRIMARY CONTAINER QUANTITY: 4
Related Searches:
VT265W
SODIUM HYALURONATE INJECTION
NSN, MFG P/N
6505014635757
NSN
6505-01-463-5757
MFG
ALLERGAN INC
Description
SPECIAL FEATURES: VITRAX 0.65 ML CANNULA BORE; USED IN CATARACT SURGERY; VISCOELASTIC GEL USED TO STABILIZE AND PROTECT EYE STRUCTURE (CORNEA) DURING SURGERY
Related Searches:
99-0186
DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505014636039
NSN
6505-01-463-6039
99-0186
DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505014636039
NSN
6505-01-463-6039
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROAMPHETAMINE SULFATE EXTENDED RELEASE CAPSULES 15MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 15 MG; BOTTLE OF 100'S
Related Searches:
DEXEDRINE SPANSULES
DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505014636039
NSN
6505-01-463-6039
DEXEDRINE SPANSULES
DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505014636039
NSN
6505-01-463-6039
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROAMPHETAMINE SULFATE EXTENDED RELEASE CAPSULES 15MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 15 MG; BOTTLE OF 100'S
Related Searches:
NDC00007-3514-20
DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505014636039
NSN
6505-01-463-6039
NDC00007-3514-20
DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505014636039
NSN
6505-01-463-6039
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROAMPHETAMINE SULFATE EXTENDED RELEASE CAPSULES 15MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 15 MG; BOTTLE OF 100'S
Related Searches:
99-0185
DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505014636040
NSN
6505-01-463-6040
99-0185
DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505014636040
NSN
6505-01-463-6040
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROAMPHETAMINE SULFATE EXTENDED RELEASE CAPSULES 10MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 10 MG; BOTTLE OF 100'S
Related Searches:
DEXEDRINE SPANSULES
DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505014636040
NSN
6505-01-463-6040
DEXEDRINE SPANSULES
DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505014636040
NSN
6505-01-463-6040
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROAMPHETAMINE SULFATE EXTENDED RELEASE CAPSULES 10MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 10 MG; BOTTLE OF 100'S
Related Searches:
NDC00007-3513-20
DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505014636040
NSN
6505-01-463-6040
NDC00007-3513-20
DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505014636040
NSN
6505-01-463-6040
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROAMPHETAMINE SULFATE EXTENDED RELEASE CAPSULES 10MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 10 MG; BOTTLE OF 100'S
Related Searches:
99-0256
DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505014636912
NSN
6505-01-463-6912
99-0256
DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505014636912
NSN
6505-01-463-6912
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS DEXTROAMPHETAMINE SULFATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: GRANULE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: SOFT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROAMPHETAMINE SULFATE EXTENDED RELEASE CAPSULES 5MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: VAULT STORAGE
SPECIAL FEATURES: 5MG SPANSULE; CONTROLLED SUBSTANCE CLASSIFICATION SCHEDULE II
Related Searches:
DEXEDRINE
DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505014636912
NSN
6505-01-463-6912
DEXEDRINE
DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505014636912
NSN
6505-01-463-6912
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS DEXTROAMPHETAMINE SULFATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: GRANULE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: SOFT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROAMPHETAMINE SULFATE EXTENDED RELEASE CAPSULES 5MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: VAULT STORAGE
SPECIAL FEATURES: 5MG SPANSULE; CONTROLLED SUBSTANCE CLASSIFICATION SCHEDULE II
